Drug Watch: Multiple sclerosis
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Employers: Cancer, GLP-1 Drugs and Mental Health Driving Healthcare Costs
Read More
FDA Approves First in Class Therapy for Hereditary Angioedema
MedImpact To Offer Unbranded Ustekinumab-aekn Biosimilar
FDA Set Review Date for Imcivree for Rare Form of Obesity
Medicare Patients Face Higher Drug Costs Despite $2,000 Spending Cap
FDA Approves Tonmya for Adult Fibromyalgia